vimarsana.com
Home
Live Updates
FDA Issues Revised Draft Guidance on "Scientific Information
FDA Issues Revised Draft Guidance on "Scientific Information
FDA Issues Revised Draft Guidance on "Scientific Information on Unapproved Uses Communications" | Foley Hoag LLP
On October 23, 2023, FDA published a draft guidance document to provide detailed recommendations to industry regarding the communication of unapproved uses of approved or cleared drugs...
Related Keywords
,
Scientific Information On Unapproved Uses Communications ,
Drug Administration ,
Device Manufacturer Communications With Payors ,
Key Takeaways ,
Communications From Firms ,
Unapproved Uses ,
Cleared Medical Products ,
Distributing Scientific ,
Medical Publications ,
Unapproved New Uses ,
Draft Guidance ,
Unsolicited Requests ,
Off Label Information About Prescription Drugs ,
Medical Devices ,
Formulary Committees ,
Similar Entities ,
Regulatory Considerations ,
Prescription Drug Use Related Software ,
Federal Food ,
Cosmetics Act ,
Differences Between ,